Chandigarh, 3rd September 2025: Jindal IVF, a leading institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) in North India, successfully hosted the 21st edition of its flagship ART Update CME on 31st August 2025 in Chandigarh. Themed around “Innovations in Infertility Management and Future of ART,” the event marked another significant step in advancing fertility education and strengthening clinical practice for doctors across the region.

The conference featured interactive lectures, expert-led discussions, and paper presentations, workshops with practical demonstrations, attracting enthusiastic participation from gynaecologists, embryologists, endocrinologists, urologists, and young fertility specialists.

The 21st ART Update featured a diverse range of sessions addressing critical aspects of infertility care and advancements in reproductive medicine. The program opened with a session on the Management of Endometriosis-related Infertility using Non-Invasive EFI Scoring, presented by Dr. Umesh Jindal. The deliberations continued with Prof. (Col.) Pankaj Talwar (President IFS), who shared valuable insights on Management Strategies in Male Infertility based on the Aphrodite Classification. The program also featured an engaging panel discussion on “Add-ons in IVF Lab: Evidence-Based Practice,” moderated by Dr. Lavleen Sodhi and Dr. Sheetal Jindal, offering practical perspectives on optimizing outcomes in assisted reproduction.

The scientific program also featured two parallel workshops designed to enhance practical learning. One explored the role and preparation of PRP in ART with demonstrations and discussions, while the other focused on fine-tuning IVF stimulation, addressing ovarian stimulation strategies, embryo transfer choices, and challenges in frozen cycles. Together, the sessions provided participants with actionable clinical insights.

All senior members of the Jindal IVF faculty, including Dr. Umesh Jindal and Dr. Sheetal Jindal, actively participated in the scientific sessions and engaged with the medical fraternity. The event also included oral paper presentations by young doctors, emphasizing Jindal IVF’s commitment to nurturing future leaders in reproductive medicine.

Reflecting on the success of the event, Dr. Sheetal Jindal, Senior Consultant and IVF-PGT Specialist at Jindal IVF, said, “The 21st ART Update once again reaffirmed our mission of creating a collaborative platform for advancing fertility care. By integrating the latest research, clinical experience, and patient-centred approaches, we aim to empower practitioners with knowledge that translates into better patient outcomes. Such academic exchanges are essential in preparing healthcare providers for the evolving challenges in reproductive medicine.”

Now in its 21st year, the ART Update has become a credible academic platform for evidence-based learning in infertility management, fertility preservation, and reproductive endocrinology. The conference also addressed misconceptions about IVF and fertility treatments, ensuring that practitioners remain aligned with global standards in ART.

With a legacy of 12,000+ successful deliveries, 20,000+ IUI procedures, and 15,000+ IVF cycles, along with innovations like PGT-HLA for Thalassemia major patients and advanced management of high-risk pregnancies, Jindal IVF continues to lead reproductive healthcare in North India, spreading hope and transforming lives.

About Jindal IVF: